Get the Stockscreener App
13.64
0.37%
-0.0432
Ginkgo Bioworks Holdings Inc stock is traded at $13.64, with a volume of 1.14M.
It is down -0.37% in the last 24 hours and up +21.70% over the past month.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering and BiosecurityThe majority of revenue in the company comes from the Biosecurity segment, which charges fees for data analytics and services.
See More
Previous Close:
$13.68
Open:
$13.91
24h Volume:
1.14M
Relative Volume:
0.80
Market Cap:
$786.31M
Revenue:
$217.11M
Net Income/Loss:
$-651.19M
P/E Ratio:
-1.0498
EPS:
-12.99
Net Cash Flow:
$-387.26M
1W Performance:
+2.02%
1M Performance:
+21.70%
6M Performance:
+24.18%
1Y Performance:
-72.52%
1-Day Range:
$13.26
$14.80
1-Week Range:
$11.85
$16.85
52-Week Range:
$5.26
$64.40
Ginkgo Bioworks Holdings Inc Stock (DNA) Company Profile
Name
Ginkgo Bioworks Holdings Inc
Sector
Industry
Phone
(877) 442-5362
Address
27 DRYDOCK AVENUE, BOSTON
Compare DNA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DNA
Ginkgo Bioworks Holdings Inc
|
13.61 | 786.31M | 217.11M | -651.19M | -387.26M | -12.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
473.04 | 123.91B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
716.12 | 78.94B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
652.27 | 39.98B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
275.00 | 35.89B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
118.78 | 28.75B | 3.30B | -501.07M | 1.03B | -2.1146 |
Ginkgo Bioworks Holdings Inc Stock (DNA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-15-24 | Downgrade | BTIG Research | Neutral → Sell |
| May-10-24 | Downgrade | William Blair | Mkt Perform → Underperform |
| Nov-14-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Nov-09-23 | Downgrade | BTIG Research | Buy → Neutral |
| Jun-02-23 | Downgrade | Goldman | Neutral → Sell |
| May-11-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Nov-29-22 | Initiated | Berenberg | Buy |
| Oct-04-22 | Initiated | Morgan Stanley | Equal-Weight |
| May-18-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Mar-02-22 | Resumed | Cowen | Outperform |
| Feb-23-22 | Initiated | Goldman | Neutral |
| Feb-01-22 | Initiated | BofA Securities | Neutral |
| Jan-28-22 | Initiated | BofA Securities | Buy |
| Jan-07-22 | Initiated | BTIG Research | Buy |
| Nov-29-21 | Initiated | Jefferies | Buy |
| Oct-13-21 | Initiated | Raymond James | Outperform |
| Oct-12-21 | Initiated | William Blair | Outperform |
| Sep-20-21 | Initiated | HSBC Securities | Buy |
View All
Ginkgo Bioworks Holdings Inc Stock (DNA) Latest News
Ginkgo Bioworks (NYSE:DNA) Shares Gap DownShould You Sell? - MarketBeat
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Sold by JPMorgan Chase & Co. - MarketBeat
Ginkgo Bioworks' chief accounting officer sells $4,933 in stock - MSN
Ginkgo Bioworks (DNA) Upgraded to Strong Buy: Here's What You Should Know - MSN
Ginkgo Bioworks CFO Dmytruk sells $9,947 in stock By Investing.com - Investing.com South Africa
Ginkgo Bioworks CFO Dmytruk sells $9,947 in stock - Investing.com India
Ginkgo Bioworks (NYSE:DNA) Trading 7.9% HigherHere's Why - MarketBeat
Strength Seen in Ginkgo Bioworks (DNA): Can Its 14.5% Jump Turn into More Strength? - Yahoo Finance
Ginkgo Bioworks to Host 6th Annual Ferment as Boston-based Conference Series - PR Newswire
Ginkgo Bioworks (NYSE:DNA) Stock Price Down 6.3%Time to Sell? - MarketBeat
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Position Trimmed by JPMorgan Chase & Co. - Defense World
Ginkgo Bioworks (NYSE:DNA) Shares Up 9.7%What's Next? - MarketBeat
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Sold by PFG Investments LLC - MarketBeat
Top 5 CRISPR Companies To Invest In (February 2025) - Securities.io
Vanguard Group Inc Reduces Stake in Ginkgo Bioworks Holdings Inc - GuruFocus.com
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Moves -0.24%: What You Should Know - MSN
Ginkgo Bioworks: Declining Core Revenue And High Cash Burn Echo Amyris' Path (NYSE:DNA) - Seeking Alpha
Africa CDC and Ginkgo Bioworks Announce Collaboration to Strengthen Laboratory Network Capacity Across African Union Member States - Marketscreener.com
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Stock Position Reduced by Exchange Traded Concepts LLC - MarketBeat
Ginkgo (DNA) to Report Q2 Earnings: What's in the Cards? - MSN
Is BioLife Solutions (BLFS) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Sold by Barclays PLC - MarketBeat
Ginkgo Automation to Deploy Flexible Laboratory Automation System for Cutting-Edge Biofuels and Bioproducts Research at Great Lakes Bioenergy Research Center (GLBRC) - Marketscreener.com
Ginkgo Bioworks Secures Major Lab Automation Contract with DOE Research Center at UW-Madison - StockTitan
Critical Comparison: Senti Biosciences (NASDAQ:SNTI) and Ginkgo Bioworks (NYSE:DNA) - Defense World
Ginkgo Bioworks (NYSE:DNA) Trading Up 6.4%What's Next? - MarketBeat
SaponiQx, Probius, and Ginkgo Bioworks Unite to Revolutionize Vaccine Adjuvant Development - Marketscreener.com
Ginkgo Bioworks (NYSE:DNA) Trading 9.1% HigherStill a Buy? - MarketBeat
Ginkgo Bioworks (NYSE:DNA) Shares Gap UpStill a Buy? - MarketBeat
DNAGinkgo Bioworks Holdings, Inc. Latest Stock News & Market Updates - StockTitan
Ginkgo Bioworks Partners with Universal Cells, an Astellas Company, to Advance Next-Generation iPSC-Derived Cell Therapies for Solid Tumors - PR Newswire
Ginkgo Bioworks Partners with Astellas' Universal Cells to Advance Cancer Cell Therapy Innovation - StockTitan
Ginkgo Bioworks (NYSE:DNA) Stock Price Down 9.1%What's Next? - MarketBeat
(DNA) On The My Stocks Page - Stock Traders Daily
Ginkgo Bioworks Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference - PR Newswire
Barclays PLC Trims Stock Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Ginkgo Bioworks officer sells stock for $3,796 By Investing.com - Investing.com Canada
Ginkgo Bioworks officer sells stock for $3,796 - Investing.com India
Ginkgo Bioworks (NYSE:DNA) Trading 6.5% HigherHere's Why - MarketBeat
Is ALX Oncology Holdings (ALXO) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Geode Capital Management LLC Trims Stake in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Sold by Geode Capital Management LLC - Defense World
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Sold by State Street Corp - MarketBeat
(DNA) Trading Advice - Stock Traders Daily
Ginkgo Bioworks (NYSE:DNA) Stock Price Down 7.9%Here's Why - MarketBeat
Ginkgo Bioworks Holdings Inc Stock (DNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):